[1]
Ismail, N.A. et al. 2024. COMPARISON OF DENOSUMAB AND ALENDRONATE EFFICACY AND RELATED DIABETES RISK IN PATIENTS WITH OSTEOPOROSIS. Journal of the ASEAN Federation of Endocrine Societies. 39, S1 (Jul. 2024), 54. DOI:https://doi.org/10.15605/jafes.039.S1.089.